U.S. pharma giant copyright scrapped two experimental weight loss supplements past yr—a the moment-each day capsule, lotiglipron, due to elevated liver enzymes plus a twice-day by day tablet, danuglipron, resulting from solid Uncomfortable side effects—but CEO Albert Bourla has reported the company is decided to “Enjoy and acquire” while in